Andrew Briggs has no conflicts to declare.
Transportability of Comparative Effectiveness and Cost-Effectiveness between Countries
Version of Record online: 1 JUL 2010
© 2010, International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Value in Health
Special Issue: Apples & Oranges? Assessing Comparative Effectiveness and Comparative Value in the US and Other Countries
Volume 13, Issue Supplement s1, pages S22–S25, June/July 2010
How to Cite
Briggs, A. (2010), Transportability of Comparative Effectiveness and Cost-Effectiveness between Countries. Value in Health, 13: S22–S25. doi: 10.1111/j.1524-4733.2010.00751.x
- Issue online: 1 JUL 2010
- Version of Record online: 1 JUL 2010
- 1Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study. Eur Respir J 2010;25:532–9., , , et al.
- 4Major surgery in Victoria and the United States: a comparison of hospital mortality in older patients. Crit Care Resusc 2008;10:288–95., , , .
- 11Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383–9.